PBAC score: an easy‐to‐use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding

Halimeh, Susan; Rott, Hannelore; Kappert, Günther

doi:10.1111/hae.12886

Cited by 26 publications

(14 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, the complexity of the method has limited its use in clinical practice. Alternatively, a Pictorial Blood Assessment Chart (PBAC) is a semiquantitative tool that calculates a score from the number of tampons or towels used and the degree of soiling 20 . It has been validated to correlate with the defined loss, and has been widely used for the diagnosis of HMB 21 .…”

Section: Discussionmentioning

confidence: 99%

“…Alternatively, a Pictorial Blood Assessment Chart (PBAC) is a semiquantitative tool that calculates a score from the number of tampons or towels used and the degree of soiling. 20 It has been validated to correlate with the defined loss, and has been widely used for the diagnosis of HMB. 21 However, the use of the PBAC in routine clinical care or even in the research setting is precluded due to the variety of towel or tampon products available.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A quality‐of‐life questionnaire for heavy menstrual bleeding in Thai women receiving oral antithrombotics: Assessment of the translated Menstrual Bleeding Questionnaire

Rodpetch

Manonai

Angchaisuksiri

et al. 2021

Research and Practice in Thrombosis and Haemostasis

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

A quality‐of‐life questionnaire for heavy menstrual bleeding in Thai women receiving oral antithrombotics: Assessment of the translated Menstrual Bleeding Questionnaire

Rodpetch

Manonai

Angchaisuksiri

et al. 2021

Research and Practice in Thrombosis and Haemostasis

View full text Add to dashboard Cite

“…In this study, objective assessment of menstrual blood loss was done by PBAC as devised by Halimeh et al 11 PBAC is a simple and less time-consuming procedure for objective assessment of menstrual blood loss. Using the scales as described below, the total score is calculated by adding up the sum of all scores for the sanitary napkin used in the menstrual cycle.…”

Section: Methods Applied For Various Assessment Menstrual Blood Loss Assessment Pictorial Blood Loss Assessment Chart (Pbac)mentioning

confidence: 99%

A comparative prospective observational study on the use of ulipristal acetate versus mifepristone in reduction of the size of uterine leiomyoma

Ghosh

Rakshit

2022

Asian J Med Sci

View full text Add to dashboard Cite

Background: Fibroid or uterine leiomyoma is the most common benign tumor of the uterus in the reproductive age group and found in one out of every four women. They are symptomatic in 50% of women, with the peak incidence occurring among women in their 30s or 40s. Fibroid can cause a variety of symptoms which include menstrual disturbances commonly menorrhagia and dysmenorrhea. It is a common indication of hysterectomy in Indians. An effective medical treatment option may reduce hysterectomy-associated morbidity and mortality. This study is undertaken to evaluate the efficacy and safety of medical management of myoma and contribution in the reduction of myoma size comparing the two drugs ulipristal and mifepristone. Aims and Objectives: The study was conducted to compare reduction of menorrhagia (By pictorial blood loss assessment chart score), reduction of fibroid size (using transvaginal ultrasonography), and improvement of hemoglobin (Hb) level. We are also evaluating safety or side effects using these drugs. Materials and Methods: The study includes 210 patients who are divided into two groups. Group A includes 105 patients who are treated with tablet Ulipristal Acetate 5 mg daily for 3 months and Group B includes 105 patients who are treated with tablet mifepristone 25 mg daily for 3 months. Results: Ulipristal and mifepristone both are effective in reduction of menorrhagia and improvement of Hb levels, but Ulipristal is more effective in reduction of size of uterine myoma than mifepristone after 3 months of treatment. Conclusion: Multicentric study over a larger population is required to reach a valid conclusion.

show abstract

“…100. 2 Bleeding symptoms, including HMB, vary across the range of VWF levels, 3 even in those with the same mutations, 4 but debate continues about whether those with "low VWF" (ie, VWF 30-50 IU/dL) have "true" disease. At least two thirds of those with "low VWF" have mutations, as in the case patient, whose missense mutation is common in type 1 VWD.…”

Section: The Hematologist's Viewmentioning

confidence: 99%

Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist’s view

Ragni

2019

Hematology

View full text Add to dashboard Cite

In the childbearing years, hormonal therapy or hormonal changes in the menstrual cycle or the puerperium may be complicated by bleeding or thrombosis; however, among women with congenital disorders of hemostasis and thrombosis, the risk of bleeding or thrombosis may be increased. In women with congenital bleeding disorders, heavy menstrual bleeding is the most common bleeding symptom, and postpartum hemorrhage occurs despite treatment. Given the limitations of current therapy and the associated medical and psychological burden in women with bleeding disorders, better treatment approaches are needed to improve health outcomes and quality of life. In women with congenital thrombotic disorders, thromboembolism may complicate exogenous hormonal therapy and endogenous hormonal change during pregnancy and procedures, but risk differs by type of thrombophilia, procedure, time at risk, and thrombosis risk factors, all of which affect management. In this article, I shall consider a case-based discussion of current issues in women with congenital bleeding and clotting disorders, including heavy menstrual bleeding in a woman with VWD, postpartum hemorrhage risk in VWD, and thrombosis risk with oocyte retrieval in a woman with factor V Leiden and past thromboembolism. The goals are to review bleeding or thrombosis risk in these cases, current data, limitations of current treatment guidelines, and areas for future study.

show abstract

PBAC score: an easy‐to‐use tool to predict coagulation disorders in women with idiopathic heavy menstrual bleeding

Cited by 26 publications

References 18 publications

A quality‐of‐life questionnaire for heavy menstrual bleeding in Thai women receiving oral antithrombotics: Assessment of the translated Menstrual Bleeding Questionnaire

A quality‐of‐life questionnaire for heavy menstrual bleeding in Thai women receiving oral antithrombotics: Assessment of the translated Menstrual Bleeding Questionnaire

A comparative prospective observational study on the use of ulipristal acetate versus mifepristone in reduction of the size of uterine leiomyoma

Case-based discussion on the implications of exogenous estrogens in hemostasis and thrombosis: the hematologist’s view

Contact Info

Product

Resources

About